Summary:
In children and adolescents with type 1 diabetes using continuous glucose monitoring (CGM), an intensive, integrated weekly telehealth intervention significantly improved glycemic control (reduced HbA1c and enhanced time in range) compared to standard care with multiple daily insulin injections (MDIs), though it was associated with increased patient and caregiver engagement demands but no significant adverse effects.
| PICO | Description |
|---|---|
| Population | Children and adolescents with type 1 diabetes using FreeStyle Libre 2 continuous glucose monitoring (CGM) and multiple daily insulin injections (MDIs). |
| Intervention | Intensive, integrated telehealth intervention involving weekly remote monitoring and personalized feedback over 12 weeks. |
| Comparison | Standard diabetes care with multiple daily insulin injections (MDIs) and routine clinical follow-up without telehealth intervention. |
| Outcome | The telehealth intervention significantly improved glycemic control, demonstrated by a reduction in HbA1c levels and increased time-in-range glucose values. The intervention was well tolerated, though it required increased engagement from patients and caregivers without additional adverse effects. |
Source: Deeb, Asma, et al. “Effect of an Intensive, Integrated Telehealth Intervention on Glycemic Control in Children and Adolescents With Type 1 Diabetes Using Continuous Glucose Monitoring: A Randomized, Crossover Trial.” Read article here.
